Is there a plateau in the survival curve after autologous transplantation in patients with intermediate and high-risk acute myeloid leukemia? A 20-year single institution experience

HDM201 in Combination With MBG453 or Venetoclax in Patients With Acute Myeloid Leukemia (AML) or High-risk Myelodysplastic Syndrome (MDS)

Case Medical Research ◽

10.31525/ct1-nct03940352 ◽

2019 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Myeloid Leukemia ◽

Faculty Opinions recommendation of Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.10197.467594 ◽

2006 ◽

Author(s):

Mayumi Mori

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Myeloid Leukemia ◽

Prognostic Models ◽

Intensive Chemotherapy ◽

Faculty Opinions recommendation of A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1119427.575617 ◽

2008 ◽

Author(s):

Arati Rao

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Myeloid Leukemia ◽

Low Dose ◽

Randomized Study ◽

Front Line ◽

Line Therapy ◽

Low Dose Cytarabine ◽

Effect of rhG-CSF Combined with Decitabine Prophylaxis on Relapse in High-Risk Acute Myeloid Leukemia Patients after Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized, Controlled, Phase 2 Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3487801 ◽

2019 ◽

Author(s):

Lei Gao ◽

Yanqi Zhang ◽

Sanbin Wang ◽

Peiyan Kong ◽

Yi Su ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

High Risk ◽

Myeloid Leukemia ◽

Phase 2 ◽

Open Label ◽

Hematopoietic Stem ◽

Randomized Controlled ◽

Phase 2 Trial ◽

Effect of rhG-CSF Combined with Decitabine Prophylaxis on Relapse in High-Risk Acute Myeloid Leukemia Patients after Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized, Controlled, Phase 2 Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3487826 ◽

2019 ◽

Author(s):

Lei Gao ◽

Yanqi Zhang ◽

Sanbin Wang ◽

Peiyan Kong ◽

Yi Su ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

High Risk ◽

Myeloid Leukemia ◽

Phase 2 ◽

Open Label ◽

Hematopoietic Stem ◽

Randomized Controlled ◽

Phase 2 Trial ◽

A Real Life Turkish Experience Of Venetoclax Treatment In High Risk Myelodysplastic Syndrome And Acute Myeloid Leukemia

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2021.04.004 ◽

2021 ◽

Author(s):

Aliihsan Gemici ◽

Fahir Ozkalemkas ◽

Mehmet Hilmi Dogu ◽

Atakan Tekinalp ◽

Inci Alacacioglu ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Myeloid Leukemia ◽

Real Life ◽

Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factors

Leukemia ◽

10.1038/sj.leu.2402591 ◽

2002 ◽

Vol 16 (9) ◽

pp. 1615-1621 ◽

Cited By ~ 42

Author(s):

M Oosterveld ◽

◽

P Muus ◽

S Suciu ◽

C Koller ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Prognostic Factors ◽

High Risk ◽

Myeloid Leukemia ◽

Secondary Acute Myeloid Leukemia ◽

Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamide, and ATG for allogeneic stem cell transplantation in elderly patients with relapsed or high-risk acute myeloid leukemia

Annals of Hematology ◽

10.1007/s00277-011-1253-9 ◽

2011 ◽

Vol 91 (1) ◽

pp. 47-55 ◽

Cited By ~ 14

Author(s):

Jens Marcus Chemnitz ◽

Marie von Lilienfeld-Toal ◽

Udo Holtick ◽

Sebastian Theurich ◽

Alexander Shimabukuro-Vornhagen ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

High Risk ◽

Stem Cell Transplantation ◽

Elderly Patients ◽

Cell Transplantation ◽

Allogeneic Stem Cell Transplantation ◽

Myeloid Leukemia ◽

Conditioning Regimen ◽

TCTAP C-005 High Risk Percutaneous Coronary Intervention in the Setting of Acute Myeloid Leukemia with Severe Bicytopenia

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2021.03.107 ◽

2021 ◽

Vol 77 (14) ◽

pp. S50-S52

Author(s):

Kogulakrishnan Kaniappan ◽

Ahmad Khairuddin Mohamed Yusof ◽

Rhuban Sundran

Keyword(s):

Percutaneous Coronary Intervention ◽

Acute Myeloid Leukemia ◽

High Risk ◽

Myeloid Leukemia ◽

Coronary Intervention ◽

Percutaneous Coronary ◽

Intensive chemotherapy vs. hypomethylating agents in older adults with newly diagnosed high-risk acute myeloid leukemia: A single center experience

Leukemia Research ◽

10.1016/j.leukres.2018.10.011 ◽

2018 ◽

Vol 75 ◽

pp. 29-35 ◽

Cited By ~ 4

Author(s):

Pankit Vachhani ◽

Raed Al Yacoub ◽

Austin Miller ◽

Fan Zhang ◽

Tara L. Cronin ◽

...

Keyword(s):

Older Adults ◽

Acute Myeloid Leukemia ◽

High Risk ◽

Myeloid Leukemia ◽

Intensive Chemotherapy ◽

Hypomethylating Agents ◽

Newly Diagnosed ◽

Single Center ◽

Single Center Experience ◽